Bromfenac ophthalmic solution for the prevention of postoperative pain in patients undergoing cataract surgery

Trial Profile

Bromfenac ophthalmic solution for the prevention of postoperative pain in patients undergoing cataract surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2012

At a glance

  • Drugs Bromfenac (Primary)
  • Indications Ocular pain; Postoperative pain
  • Focus Therapeutic Use
  • Sponsors ISTA Pharmaceuticals
  • Most Recent Events

    • 05 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top